Other
Depth of Anesthesia
5
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Depth of Anesthesia is an early-stage landscape with 5 programs across 3 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Fresenius Kabi Oncology Ltd., Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical5
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
12
clinical trials
Completed9 · 75%
Unknown status1 · 8%
Terminated1 · 8%
Not yet recruiting1 · 8%
Clinical Trials
Trial Activity
12 trials
Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
Completed·—·Phase 4·NCT06862349·120 enrolled
The Effect of Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
Completed·—·N/A·NCT06862245·120 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)